Solventum Corporation (SOLV) has a MoatMap StockRank of 68/100 based on Quality (59/100), Value (50/100), and Momentum (43/100) factor scores. The current signal is BUY. Solventum is a recent spin-off from 3M burdened with high leverage and slow organic growth, representing a turnaround story that violates our Terry Smith lens.
Solventum Corporation, a recent spin-off from 3M, develops and manufactures a broad portfolio of healthcare products, including medical surgical solutions, dental technologies, and health information systems. The company leverages its established brand reputation, deep customer relationships, and global distribution network to maintain a significant presence across diverse healthcare markets.
| Price | $76.43 |
| Market Cap | $13.2B |
| P/E (TTM) | 9.34 |
| P/E (Forward) | 10.80 |
| Price/Book | 2.62 |
| Return on Equity | 34.8% |
| Return on Invested Capital | 18.5% |
| Debt/Equity | 106.46 |
| Gross Margin | 53.7% |
| Operating Margin | 5.6% |
| Revenue Growth | -3.0% |
| Free Cash Flow | $379M |
Solventum Corporation operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).